|
1
|
Cao A and Galanello R: Beta-thalassemia. Genet Med. 12:61–76. 2010.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Aziz NA, Taib WW, Kharolazaman NK, Ismail I, Al-Jamal HAN, Jamil NWWA, Esa E and Ibrahim H: Evidence of new intragenic HBB haplotypes model for the prediction of beta-thalassemia in the Malaysian population. Sci Rep. 11(16772)2021.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Haiyuni MY, Aziee S, Nasir A, Abdullah WZ and Johan MF: LARP2 DNA methylation in transfusion-dependent haemoglobin E-beta (HBE/β) and β-thalassaemia major patients. Mal J Med Health Sci. 15:46–53. 2019.
|
|
4
|
Fucharoen S and Weatherall DJ: The hemoglobin E thalassemias. Cold Spring Harb Perspect Med. 2(a011734)2012.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Clark RJ, Tan CC, Preza GC, Nemeth E, Ganz T and Craik DJ: Understanding the structure/activity relationships of the iron regulatory peptide hepcidin. Chem Biol. 18:336–343. 2011.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Mackenzie EL, Iwasaki K and Tsuji Y: Intracellular iron transport and storage: From molecular mechanisms to health implications. Antioxid Redox Signal. 10:997–1030. 2008.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Kaplan J, Ward DM and De Domenico I: The molecular basis of iron overload disorders and iron-linked anemias. Int J Hematol. 93:14–20. 2011.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Piperno A, Pelucchi S and Mariani R: Inherited iron overload disorders. Transl Gastroenterol Hepatol. 5(25)2020.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Mariani R, Trombini P, Pozzi M and Piperno A: Iron metabolism in thalassemia and sickle cell disease. Mediterr J Hematol Infect Dis. 1(e2009006)2009.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Taher AT and Saliba AN: Iron overload in thalassemia: Different organs at different rates. Hematology Am Soc Hematol Educ Program. 2017:265–271. 2017.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Jones E, Pasricha SR, Allen A, Evans P, Fisher CA, Wray K, Premawardhena A, Bandara D, Perera A, Webster C, et al: Hepcidin is suppressed by erythropoiesis in hemoglobin E β-thalassemia and β-thalassemia trait. Blood. 125:873–880. 2015.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Locatelli F, Andrulli S, Pecchini F, Pedrini L, Agliata S, Lucchi L, Farina M, La Milia V, Grassi C, Borghi M, et al: Effect of high-flux dialysis on the anaemia of haemodialysis patients. Nephrol Dial Transplant. 15:1399–1409. 2000.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Olivieri NF, Muraca GM, O'Donnell A, Premawardhena A, Fisher C and Weatherall DJ: Studies in haemoglobin E beta-thalassaemia. Br J Haematol. 141:388–397. 2008.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Hirsch RE, Sibmooh N, Fucharoen S and Friedman JM: HbE/β-thalassemia and oxidative stress: The key to pathophysiological mechanisms and novel therapeutics. Antioxid Redox Signal. 26:794–813. 2017.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Peslova G, Petrak J, Kuzelova K, Hrdy I, Halada P, Kuchel PW, Soe-Lin S, Ponka P, Sutak R, Becker E, et al: Hepcidin, the hormone of iron metabolism, is bound specifically to alpha-2-macroglobulin in blood. Blood. 113:6225–6236. 2009.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Hassan Al-K, Azemin W-A, Dharmaraj S and Mohd K: Cytotoxic effect of hepcidin (th1-5) on human breast cancer cell line (mcf7). Jurnal Teknologi 77(3), 2015. doi:10.11113/jt.v77.6009. Accessed May 11, 2021.
|
|
17
|
Donovan A, Lima CA, Pinkus JL, Pinkus GS, Zon LI, Robine S and Andrews NC: The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis. Cell Metab. 1:191–200. 2005.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Zhang DL, Senecal T, Ghosh MC, Ollivierre-Wilson H, Tu T and Rouault TA: Hepcidin regulates ferroportin expression and intracellular iron homeostasis of erythroblasts. Blood. 118:2868–2877. 2011.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Donovan A, Brownlie A, Zhou Y, Shepard J, Pratt SJ, Moynihan J, Paw BH, Drejer A, Barut B, Zapata A, et al: Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature. 403:776–781. 2000.PubMed/NCBI View Article : Google Scholar
|
|
20
|
McKie AT, Marciani P, Rolfs A, Brennan K, Wehr K, Barrow D, Miret S, Bomford A, Peters TJ, Farzaneh F, et al: A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation. Mol Cell. 5:299–309. 2000.PubMed/NCBI View Article : Google Scholar
|
|
21
|
De Domenico I, Ward DM, Langelier C, Vaughn MB, Nemeth E, Sundquist WI, Ganz T, Musci G and Kaplan J: The molecular mechanism of hepcidin-mediated ferroportin down-regulation. Mol Biol Cell. 18:2569–2578. 2007.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Pak M, Lopez MA, Gabayan V, Ganz T and Rivera S: Suppression of hepcidin during anemia requires erythropoietic activity. Blood. 108:3730–3735. 2006.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Ganz T: Hepcidin and iron regulation, 10 years later. Blood. 117:4425–4433. 2011.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Olivieri NF, Pakbaz Z and Vichinsky E: Hb E/beta-thalassaemia: A common & clinically diverse disorder. Indian J Med Res. 134(522)2011.PubMed/NCBI
|
|
26
|
Moradi G and Ghaderi E: Chronic disease program in Iran: Thalassemia control program. Chronic Diseases J. 1:98–106. 2013.
|
|
27
|
De Sanctis V, Soliman A and Yassin M: Iron overload and glucose metabolism in subjects with β-thalassaemia major: An overview. Curr Diabetes Rev. 9:332–341. 2013.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Rund D and Rachmilewitz E: Beta-Thalassemia. N Engl J Med. 353:1135–1146. 2005.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Handa P, Morgan-Stevenson V, Maliken BD, Nelson JE, Washington S, Westerman M, Yeh MM and Kowdley KV: Iron overload results in hepatic oxidative stress, immune cell activation, and hepatocellular ballooning injury, leading to nonalcoholic steatohepatitis in genetically obese mice. Am J Physiol Gastrointest Liver Physiol. 310:G117–G127. 2016.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Giesbrandt KJ, Bolan CW, Shapiro BP, Edwards WD and Mergo PJ: Diffuse diseases of the myocardium: MRI-pathologic review of cardiomyopathies with dilatation. AJR Am J Roentgenol. 200:W274–W282. 2013.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Buja LM and Roberts WC: Iron in the heart: Etiology and clinical significance. Am J Med. 51:209–221. 1971.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Guzelbey T, Gurses B, Ozturk E, Ozveren O, Sarsilmaz A and Karasu E: Evaluation of iron deposition in the adrenal glands of β thalassemia major patients using 3-tesla MRI. Iran J Radiol. 13(e36375)2016.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Coyne DW: Hepcidin: Clinical utility as a diagnostic tool and therapeutic target. Kidney Int. 80:240–244. 2011.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, Ganz T and Kaplan J: Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science. 306:2090–2093. 2004.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Ward DM and Kaplan J: Ferroportin-mediated iron transport: Expression and regulation. Biochim Biophys Acta. 1823:1426–1433. 2012.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Weizer-Stern O, Adamsky K, Amariglio N, Rachmilewitz E, Breda L, Rivella S and Rechavi G: mRNA expression of iron regulatory genes in beta-thalassemia intermedia and beta-thalassemia major mouse models. Am J Hematol. 81:479–483. 2006.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Adamsky K, Weizer O, Amariglio N, Breda L, Harmelin A, Rivella S, Rachmilewitz E and Rechavi G: Decreased hepcidin mRNA expression in thalassemic mice. Br J Haematol. 124:123–124. 2004.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Gardenghi S, Marongiu MF, Ramos P, Guy E, Breda L, Chadburn A, Liu Y, Amariglio N, Rechavi G, Rachmilewitz EA, et al: Ineffective erythropoiesis in beta-thalassemia is characterized by increased iron absorption mediated by down-regulation of hepcidin and up-regulation of ferroportin. Blood. 109:5027–5035. 2007.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Finberg KE: Ironing out an approach to alleviate the hypoferremia of acute inflammation. Haematologica. 106:326–328. 2021.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Stefanopoulos D, Nasiri-Ansari N, Dontas I, Vryonidou A, Galanos A, Psaridi L, Fatouros IG, Mastorakos G, Papavassiliou AG, Kassi E and Tournis S: Fibroblast growth factor 23 (FGF23) and klotho protein in beta-Thalassemia. Horm Metab Res. 52:194–201. 2020.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Renassia C and Peyssonnaux C: New insights into the links between hypoxia and iron homeostasis. Curr Opin Hematol. 26:125–130. 2019.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Pasricha SR, Frazer DM, Bowden DK and Anderson GJ: Transfusion suppresses erythropoiesis and increases hepcidin in adult patients with β-thalassemia major: A longitudinal study. Blood. 122:124–133. 2013.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Hendy OM, Allam M, Allam A, Attia MH, El Taher S, Eldin MM and Ali A: Hepcidin levels and iron status in beta-thalassemia major patients with hepatitis C virus infection. Egypt J Immunol. 17:33–44. 2010.PubMed/NCBI
|
|
44
|
Ganz T and Nemeth E: Hepcidin and iron homeostasis. Biochim Biophys Acta. 1823:1434–1443. 2012.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Hossaini SKE and reza Haeri M: Association between serum levels of hepcidin and ferritin in patients with thalassemia major and intermedia, the role of iron chelator. J Hematopathol. 12:143–147. 2019.
|
|
46
|
Jagadishkumar K, Yerraguntla N and Vaddambal MG: Serum hepcidin levels in children with beta Thalassemia major. Indian Pediatr. 55:911–912. 2018.PubMed/NCBI
|
|
47
|
Chauhan R, Sharma S and Chandra J: What regulates hepcidin in poly-transfused β-Thalassemia Major: Erythroid drive or store drive? Indian J Pathol Microbiol. 57:39–42. 2014.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Ucler R, Kara E, Atmaca M, Olmez S, Alay M, Dirik Y and Bora A: A rare presentation of transfusional hemochromatosis: Hypogonadotropic hypogonadism. Case Rep Endocrinol. 2015(493091)2015.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Mishra AK and Tiwari A: Iron overload in Beta thalassaemia major and intermedia patients. Maedica (Bucur). 8:328–332. 2013.PubMed/NCBI
|
|
50
|
Abbass SAR and Defer IH: Some biochemical parameters in Iraqi patients with thalassemia and related with DM1. Int J Chem. 1:46–56. 2011.
|
|
51
|
Abdullah UYH, Ibrahim HM, Mahmud NB, Salleh MZ, Teh LK, Noorizhab MNFB, Zilfalil BA, Jassim HM, Wilairat P and Fucharoen S: Genotype-phenotype correlation of β-thalassemia in Malaysian population: Toward effective genetic counseling. Hemoglobin. 44:184–189. 2020.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Al-Hakeim HK, Auda FM and Ali BM: Lack of correlation between non-labile iron parameters, total carbonyl and malondialdehyde in major thalassemia. J Clin Biochem Nutr. 55:203–206. 2014.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Khera R, Singh T, Khuana N, Gupta N and Dubey AP: HPLC in characterization of hemoglobin profile in thalassemia syndromes and hemoglobinopathies: A clinicohematological correlation. Indian J Hematol Blood Transfus. 31:110–115. 2015.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Abdullah UYH, Ibrahim HM, Jassim HM, Salleh MZ, Kek TL, Fakhruzzaman Bin Noorizhab MN, Zilfalil BA, Wilairat P and Fucharoen S: Relative proteome quantification of alpha, beta, gamma and delta globin chains in early eluting peaks of Bio-Rad variant II® CE-HPLC of hemoglobin from healthy and beta-thalassemia subjects in Malaysia. Biochem Biophys Rep. 18(100635)2019.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Tatu T: Laboratory Diagnosis of β-Thalassemia and HbE. In: Beta Thalassemia. Marwa Z and Tamer H (eds). IntechOpen, 2020. doi:10.5772/intechopen.90317.
|
|
56
|
Lim WF, Muniandi L, George E, Sathar J, Teh LK and Lai MI: HbF in HbE/β-thalassemia: A clinical and laboratory correlation. Hematology. 20:349–353. 2015.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Ivaldi G, Barberio G, Harteveld CL and Giordano P: HbA2 measurements in β-thalassemia and in other conditions. Thalassemia Rep. 4:45–48. 2014.
|
